Source · Prevention of Future Deaths

Jane Lawrence

Ref: 2026-0399 Date: 16 Jul 2026 Coroner: Sonia Hayes Area: Essex 56-day deadline: 8 Dec 2026 est. (estimated from the Judiciary.uk publication date) Responses identified: 1 of 1 1 response identified · 1 indexed addressee

Response deadline: 8 December 2026 (estimated from the Judiciary.uk publication date).

Coroner's concerns

Coroner’s Concerns (source excerpt)
There is a risk of non-conveyance to hospital of a patient following an episode of Severe Hypoglycemia when following the JRCALC Guideline flowchart. (1) A paramedic first responder attended Mrs Lawrence for an episode of hypoglycemia with altered consciousness and administered treatment in accordance with the JRCALC Guidelines (JRCALC).
View full coroner's concerns
There is a risk of non-conveyance to hospital of a patient following an episode of Severe Hypoglycemia when following the JRCALC Guideline flowchart.

(1) A paramedic first responder attended Mrs Lawrence for an episode of hypoglycemia with altered consciousness and administered treatment in accordance with the JRCALC Guidelines (JRCALC). The episode was considered within the flowchart in the JRCALC to be in the “Severe” range. Mrs Lawrence was treated with 3 boluses of IV Glucose in accordance with the JRCALC and then given complex carbohydrates. Mrs Lawrence was not conveyed to hospital or considered for further care and was given safety netting advice.

The JRCALC flowchart for severe hypoglycaemia following completion of treatment states if the blood glucose has returned to >4mmol/L directs the healthcare practitioner back to “MILD” section of the flowchart. This then does not signpost or direct the healthcare practitioner to consider the pathway for patients who may require further care that is within a separate part of the JRCALC. There is a risk that a patient will not be considered for further care and particularly when they are prescribed Sulphonylureas with an increased risk of repeated episodes.

(2) In the JRCALC the flowchart for Severe hypoglycaemia gives differing time thresholds for administration of IV Glucose than the administration of medication part of the JRCALC ad may lead to confusion.

(3) East of England Ambulance Service NHS Trust issued a Red Patient Safety Notice on 9 July 2026 on the risk of non-conveyance highlighting further specific considerations as advised by the JRCALC and BNF so they are not missed. Other ambulance Trusts may not be aware of the potential discrepancy with the flowchart.

Responses 1 respondent

Association of Ambulance Chief Executives

NHS / Health Body PDF ↗
AI-generated response summary

The Association of Ambulance Chief Executives (AACE) is undertaking a full review of the JRCALC glycaemic emergencies' guideline, specifically the hypoglycaemia management flowchart, to revise it to include detail on hospital conveyance and address time discrepancies. AACE has also shared the coroner's concerns with all UK ambulance services and highlighted them at a national medical directors' meeting to raise awareness.

View full response
Dear Ms Hayes JANE LAWRENCE (DECEASED) I am writing in response to the preventing future deaths report in my capacity as managing director of the Association of Ambulance Chief Executives (AACE). On behalf of AACE, I would like to extend our sincere condolences to Jane’s family. AACE is a private company owned by the English and Welsh Ambulance NHS trusts. It exists to provide ambulance services with a central organisation that supports, co-ordinates and assists with the implementation of nationally agreed policy. Our primary focus is the ongoing development of UK NHS ambulance services and the improvement of patient care. It is a company owned by NHS organisations and possesses the intellectual property rights of the Joint Royal Colleges Ambulance Liaison Committee (JRCALC) UK ambulance service clinical practice guidelines (the “JRCALC guidelines”). AACE is not constituted to mandate or instruct ambulance services, however, it has national influence via the regular meetings of ambulance chief executives and chairs along with a network of national specialist groups. The JRCALC guidelines are advisory and have been developed to assist paramedics working in UK ambulance services in making decisions about the management of patients’ health, including treatments and to support clinical practice. We recognise that the guidelines cannot always contain all the information necessary for determining appropriate care and cannot address all individual situations; therefore, we expect that paramedics using JRCALC guidelines ensure they have the appropriate knowledge and skills to enable suitable interpretation. We respond in relation to your matters of concern: There is a risk of non-conveyance to hospital of a patient following an episode of Severe Hypoglycemia when following the JRCALC Guideline flowchart. Your matters of concern were brought to the attention of JRCALC, and specifically to our clinical leads for the glycaemic emergencies’ guideline. These clinical leads are our expert advisors who have a background of diabetes knowledge, and they include an endocrinologist and a paediatrician. We have held our first guideline group meeting, and we are undertaking a full review of the glycaemic emergencies’ guideline along with the associated medicines used to treat hypoglycaemia. We are

[Page 2] currently reviewing the sections of guideline that relate to hypoglycaemia management. Registered paramedics will contribute to this review process to ensure clarity and ease of implementation. On initial review of the guideline, we agree that the hypoglycaemia management flowchart does not contain detail of considerations of whether the patient needs to go to hospital. We are looking to revise this specifically as well as considering the guideline in its entirety. We will also address the different time thresholds for administration of IV glucose that you highlighted as a discrepancy. Our aim is to complete our review and subsequent update of the glycaemic emergencies’ guideline over the next few months. The revised guideline will be presented to JRCALC for approval, and then for final ratification by the national ambulance services medical directors’ group (NASMeD). New and updated guidelines are released onto the JRCALC App at regular intervals throughout the year. Ambulance services are given at least four weeks’ notice of planned updates via senior clinicians so that they can prepare accordingly and consider any local education that may be required to support new guidance. Another action we have taken was to share your matters of concern by email with all UK ambulance services via medical directors and quality and risk directors. We suggested that they consider raising awareness amongst clinicians of the risks of not conveying a patient to hospital after a hypoglycaemic episode, particularly if a patient is taking sulphonylurea medications. In addition to this, we highlighted the concerns you raised at the national ambulance service medical directors (NASMeD) meeting on 18 August. I hope this is helpful. Please do not hesitate to contact me should you require any further information.

Report sections

Investigation and inquest
On 20 February 2025 I commenced an investigation into the death of Jane LAWRENCE, AGE 60. The investigation has not yet concluded, and the inquest has not yet been heard.
Circumstances of the death
Jane Lawrence died in hospital on 14 February 2025. On 24 January 2025 Mrs Lawrence had an episode of severe hypoglycaemia with altered consciousness and was treated by a paramedic with 3 boluses of IV Glucose administered over a period of approximately 24 minutes and then complex carbohydrates in accordance with the JRCALC Guidelines.

Mrs Lawrence then ate a meal and took her usual medication and went to sleep. Mrs Lawrence was found unresponsive the next morning, given emergency treatment and conveyed to hospital. Mrs Lawrence was found to have a profound neurological injury that did not respond to treatment.

Similar PFD reports Shared signals

Responses identified

All listed responses identified

Organisations named in PFD reports are normally expected to respond within 56 days. Deadline: 8 Dec 2026 (estimated from the Judiciary.uk publication date).

Sent to

  • Association of Ambulance Chief Executives

Source links

Data: judiciary.uk.